文献速递乳腺技术与安全US

自动乳腺超声与手持超声评估乳腺癌患者腋窝淋巴结的比较

Automated Versus Handheld Breast Ultrasound for Evaluating Axillary Lymph Nodes in Patients With Breast Cancer.
PubMed 文献 · Korean J Radiol · 2024-01-17

本研究回顾性分析377例早期乳腺癌(≤T2)患者共385个乳腺癌,比较自动乳腺超声(ABUS)与手持超声(HHUS)以病理为参考标准预测腋窝淋巴结转移及高负荷转移(≥3枚)的诊断性能;ABUS预测腋窝淋巴结转移的敏感度43.6%、特异度95.1%,与HHUS无显著差异(P≥0.53),两者一致性高(Cohen's kappa=0.883)。

要点

  • ABUS预测腋窝淋巴结转移敏感度43.6%、特异度95.1%,与HHUS无显著差异(P≥0.53)。
  • ABUS预测高负荷转移(≥3枚)敏感度70.0%、特异度89.6%,与HHUS无显著差异(P≥0.57)。
  • ABUS与HHUS对腋窝淋巴结可见性及超声表现的一致性为95.9%(Cohen's kappa=0.883)。

核心结论

  • ABUS诊断早期乳腺癌腋窝淋巴结转移的敏感度有限,但性能与HHUS相当,仍具实用性。

研究设计与样本

  • 回顾性研究,纳入2017年9月至2018年5月间新诊断早期乳腺癌(≤T2)并同时行腋窝ABUS和HHUS检查的女性377例(385个乳腺癌),以病理结果为参考标准。

关键影像表现/征象

  • ABUS在246个腋窝(63.9%,246/385)中识别出良性表现或可疑腋窝淋巴结,平均每例1.4±0.8枚。

诊断标准与关键数值

  • ABUS预测腋窝淋巴结转移(按乳腺分析):敏感度43.6%(44/101)、特异度95.1%(270/284)、阳性预测值75.9%(44/58)、阴性预测值82.6%(270/327)、准确率81.6%(314/385)。
  • HHUS预测腋窝淋巴结转移(按乳腺分析):敏感度41.6%(42/101)、特异度95.1%(270/284)、阳性预测值75.0%(42/56)、阴性预测值82.1%(270/329)、准确率81.0%(312/385),与ABUS无显著差异(P≥0.53)。
  • ABUS预测高负荷转移(≥3枚淋巴结):敏感度70.0%(21/30)、特异度89.6%(318/355)、阳性预测值36.2%(21/58)、阴性预测值97.3%(318/327)、准确率88.1%(339/385)。
  • HHUS预测高负荷转移(≥3枚淋巴结):敏感度66.7%(20/30)、特异度89.9%(319/355)、阳性预测值35.7%(20/56)、阴性预测值97.0%(319/329)、准确率88.1%(339/385),与ABUS无显著差异(P≥0.57)。
  • ABUS与HHUS对淋巴结可见性及超声表现的一致性为95.9%(236/246;Cohen's kappa=0.883)。

临床应用与阅片要点

  • ABUS预测腋窝淋巴结转移的敏感度有限(43.6%),但诊断性能与HHUS相当,可作为HHUS的补充工具用于腋窝评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Automated breast ultrasound (ABUS) is a relevant imaging technique for early breast cancer diagnosis and is increasingly being used as a supplementary tool for mammography. This study compared the performance of ABUS and handheld ultrasound (HHUS) in detecting and characterizing the axillary lymph nodes (LNs) in patients with breast cancer.

MATERIALS AND METHODS: We retrospectively reviewed the medical records of women with recently diagnosed early breast cancer (≤ T2) who underwent both ABUS and HHUS examinations for axilla (September 2017-May 2018). ABUS and HHUS findings were compared using pathological outcomes as reference standards. Diagnostic performance in predicting any axillary LN metastasis and heavy nodal-burden metastases (i.e., ≥ 3 LNs) was evaluated. The ABUS-HHUS agreement for visibility and US findings was calculated.

RESULTS: The study included 377 women (53.1 ± 11.1 years). Among 385 breast cancers in 377 patients, 101 had axillary LN metastases and 30 had heavy nodal burden metastases. ABUS identified benign-looking or suspicious axillary LNs (average, 1.4 ± 0.8) in 246 axillae (63.9%, 246/385). According to the per-breast analysis, the sensitivity, specificity, positive and negative predictive values, and accuracy of ABUS in predicting axillary LN metastases were 43.6% (44/101), 95.1% (270/284), 75.9% (44/58), 82.6% (270/327), and 81.6% (314/385), respectively. The corresponding results for HHUS were 41.6% (42/101), 95.1% (270/284), 75.0% (42/56), 82.1% (270/329), and 81.0% (312/385), respectively, which were not significantly different from those of ABUS (P ≥ 0.53). The performance results for heavy nodal-burden metastases were 70.0% (21/30), 89.6% (318/355), 36.2% (21/58), 97.3% (318/327), and 88.1% (339/385), respectively, for ABUS and 66.7% (20/30), 89.9% (319/355), 35.7% (20/56), 97.0% (319/329), and 88.1% (339/385), respectively, for HHUS, also not showing significant difference (P ≥ 0.57). The ABUS-HHUS agreement was 95.9% (236/246; Cohen's kappa = 0.883).

CONCLUSION: Although ABUS showed limited sensitivity in diagnosing axillary LN metastasis in early breast cancer, it was still useful as the performance was comparable to that of HHUS.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Kim SM, Jang M, Yun B, et al. Automated Versus Handheld Breast Ultrasound for Evaluating Axillary Lymph Nodes in Patients With Breast Cancer. Korean J Radiol. 2024. PMID: 38238017. doi:10.3348/kjr.2023.0100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。